ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the stimulatory levels of cellular-mediated immunity, which plays an essential role in controlling SARS-CoV-2 infection. In fact, several studies have shown the association of lymphopenia with severe COVID-19 in patients. The aim of this study is to investigate the response of the immune system, including cell-mediated immunity and antibody production, during different stages of SARS-CoV-2 infection. Peripheral blood and serum samples were collected from patients with moderate infection, patients under medication (hospitalized), patients who had recovered, and healthy individuals ( n = 80). Flow cytometry analysis was performed on peripheral blood samples to determine the cellular immunity profile of each patient. The data showed a significant reduction in the levels of CD3 + , CD4 + , and CD8 + T cells and CD45 + cells in the moderate and under-medication groups, suggesting lymphopenia in those patients. Also, enzyme-linked immunosorbent assay (ELISA) was conducted on the serum samples to measure the levels of antibodies, including IgM and IgG, in each patient. The results revealed a significant increase in the levels of IgM in the moderate infection and under-medication patients, thus indicating the production of IgM during the first week of infection. Furthermore, changes in the levels of IgG were significantly detected among recovered patients, indicating therefore a remarkable increase during the recovery stage of SARS-CoV-2 infection and thus a strong humoral-mediated immunity. In summary, the results of this study may help us to understand the main role of the cellular immune responses, including CD3 + , CD4 + , and CD8 + T cells, against SARS-CoV-2 infection. This understanding might support the development of SARS-CoV-2 treatments and vaccines in the near future. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 in China. This virus is a serious threat to people not only in China but also worldwide, where it has been detected in over 222 countries. It has been reported that ∼3.4% of SARS-CoV-2-infected patients have died. The significance of our study relies on the fact that an enzyme-linked immunosorbent assay and flow cytometry were used to measure the levels of antibodies and cellular immune response, respectively, from clinical samples of patients infected with SARS-CoV-2.
【저자키워드】 COVID-19, SARS-CoV-2, IgG, IgM, T cells, CD4, CD8, 【초록키워드】 severe acute respiratory syndrome coronavirus 2, Vaccine, coronavirus, Hospitalized, severe COVID-19, Immunity, Cellular immune response, T cells, SARS-COV-2 infection, Infection, immune system, severe acute respiratory syndrome Coronavirus, virus, flow cytometry, ELISA, Peripheral blood, lymphopenia, China, clinical samples, enzyme-linked immunosorbent assay, T cell, cellular immunity, immune responses, Patient, recovered patients, respiratory, medication, moderate, patients, Blood, Cell-mediated immunity, association, Flow, antibody production, IgM and IgG, Support, acute respiratory syndrome, acute respiratory syndrome coronavirus, serum samples, enzyme, significant increase, help, Stage, cellular immune responses, CD45, Flow cytometry analysis, main role, peripheral blood samples, SARS-CoV-2-infected patients, serum sample, SARS-CoV-2 treatment, levels of antibodies, Affect, peripheral, CD3, Cell, enzyme-linked immunosorbent, cytometry analysis, clinical sample, shown, collected, died, significantly, reported, conducted, was performed, were used, determine, changes in, groups, reduction in, healthy individual, stimulatory, infected with SARS-CoV-2, levels of antibody, patients with moderate, SARS-CoV-2-infected patient, 【제목키워드】 T cells, IgG and IgM, Stage, peripheral, CD3, Level,